111c0e04 Abba 40e6 Ab23 2df93e429250 01
Abacavir Tablet, Film Coated
Product Images NDC 69097-514
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Abacavir (NDC 69097-514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
111c0e04 Abba 40e6 Ab23 2df93e429250 02
Abacavir Tablets, USP is a prescription medication with NDC 69097-514-03, containing 60 tablets, each tablet containing Abacavir Sulfate USP equivalent to Abacavir 300 mg. It is manufactured by Cipla Ltd. in India, and distributed by Cipla USA, Inc. in Sunrise, FL. The medication guide and warning card from the carton should be given to the patient each time Abacavi Tablets is dispensed. The package insert should be referred to for dosage and administration guidelines. The tablets should be stored at 20°C to 25°C, and not used if the safety seal under the cap is broken or missing.*
111c0e04 Abba 40e6 Ab23 2df93e429250 03
This appears to be an output of the packaging and related details of a batch of Abacavir Tablets, USP. It includes information such as the GTIN, serial number, expiry date, lot number, dosage instructions, and storage conditions. Additionally, there are warnings and precautions such as the need to keep the medication out of reach of children, and to only use it according to the directions provided. The manufacturer's name and address are also included.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
